Loading...
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer
Previous studies have demonstrated that human signal transducer and activator of transcription 3 (Stat3) and disintegrin and metalloproteinase 9 (ADAM9) are promising targets for RNA interference (RNAi)-based gene therapy for human non-small cell lung cancer (NSCLC). Thus, in the present study, the...
Saved in:
| Published in: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734062/ https://ncbi.nlm.nih.gov/pubmed/26893726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.4018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|